skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,056  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical Pharmacology in Diuretic Use
Material Type:
Article
Add to My Research

Clinical Pharmacology in Diuretic Use

Clinical journal of the American Society of Nephrology, 2019-08, Vol.14 (8), p.1248-1257 [Peer Reviewed Journal]

Copyright © 2019 by the American Society of Nephrology 2019 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.09630818 ;PMID: 30936153

Full text available

2
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
Material Type:
Article
Add to My Research

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

The Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00018-6 ;PMID: 35085503

Full text available

3
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Material Type:
Article
Add to My Research

In situ click chemistry generation of cyclooxygenase-2 inhibitors

Nature communications, 2017-02, Vol.8 (1), p.1-14, Article 1 [Peer Reviewed Journal]

Copyright Nature Publishing Group Feb 2017 ;The Author(s) 2017 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-016-0009-6 ;PMID: 28232747

Full text available

4
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
Material Type:
Article
Add to My Research

KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema

American journal of ophthalmology, 2022-06, Vol.238, p.157-172 [Peer Reviewed Journal]

2022 ;Copyright © 2022. Published by Elsevier Inc. ;Copyright Elsevier Limited Jun 2022 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.01.004 ;PMID: 35038415

Full text available

5
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Material Type:
Article
Add to My Research

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

The New England journal of medicine, 2015-03, Vol.372 (13), p.1193-1203 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Copyright © 2015 Massachusetts Medical Society. 2015 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1414264 ;PMID: 25692915

Full text available

6
Pharmacology of Corticosteroids for Diabetic Macular Edema
Material Type:
Article
Add to My Research

Pharmacology of Corticosteroids for Diabetic Macular Edema

Investigative ophthalmology & visual science, 2018-01, Vol.59 (1), p.1-12 [Peer Reviewed Journal]

Copyright 2018 The Authors 2018 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-22259 ;PMID: 29297055

Full text available

7
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial

Archives of ophthalmology (1960), 2021-07, Vol.139 (7), p.701 [Peer Reviewed Journal]

Copyright American Medical Association Jul 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2021.0606

Full text available

8
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
Material Type:
Article
Add to My Research

Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

Clinical cancer research, 2021-01, Vol.27 (1), p.276-287 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-20-2291 ;PMID: 33239433

Full text available

9
Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial
Material Type:
Article
Add to My Research

Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial

Lancet neurology, 2016-10, Vol.15 (11), p.1160-1169 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 01, 2016 ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(16)30196-X ;PMID: 27567243 ;CODEN: LANCAO

Full text available

10
Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
Material Type:
Article
Add to My Research

Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data

American journal of ophthalmology, 2016-12, Vol.172, p.72-79 [Peer Reviewed Journal]

2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.012 ;PMID: 27644589 ;CODEN: AJOPAA

Full text available

11
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
Material Type:
Article
Add to My Research

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

Eye (London), 2020-06, Vol.34 (Suppl 1), p.1-51 [Peer Reviewed Journal]

The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-020-0961-6 ;PMID: 32504038

Full text available

12
Skin-on-a-chip model simulating inflammation, edema and drug-based treatment
Material Type:
Article
Add to My Research

Skin-on-a-chip model simulating inflammation, edema and drug-based treatment

Scientific reports, 2016-11, Vol.6 (1), p.37471, Article 37471 [Peer Reviewed Journal]

Copyright Nature Publishing Group Nov 2016 ;Copyright © 2016, The Author(s) 2016 The Author(s) ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/srep37471 ;PMID: 27869150

Full text available

13
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes
Material Type:
Article
Add to My Research

Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes

British journal of ophthalmology, 2021-02, Vol.105 (2), p.216-221 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-315933 ;PMID: 32265201

Full text available

14
Icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathways
Material Type:
Article
Add to My Research

Icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathways

Biomedicine & pharmacotherapy, 2019-12, Vol.120, p.109567, Article 109567 [Peer Reviewed Journal]

2019 The Author(s) ;Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved. ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2019.109567 ;PMID: 31670031

Full text available

15
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time
Material Type:
Article
Add to My Research

Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time

Archives of ophthalmology (1960), 2022-10, Vol.140 (10), p.946 [Peer Reviewed Journal]

Copyright American Medical Association Oct 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.3131

Full text available

16
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study
Material Type:
Article
Add to My Research

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

British journal of ophthalmology, 2016-06, Vol.100 (6), p.787-795 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2015-307249 ;PMID: 26453639 ;CODEN: BJOPAL

Full text available

17
Enhancement of Hematoma Clearance With CD47 Blocking Antibody in Experimental Intracerebral Hemorrhage
Material Type:
Article
Add to My Research

Enhancement of Hematoma Clearance With CD47 Blocking Antibody in Experimental Intracerebral Hemorrhage

Stroke (1970), 2019-06, Vol.50 (6), p.1539-1547 [Peer Reviewed Journal]

2019 American Heart Association, Inc. ;ISSN: 0039-2499 ;EISSN: 1524-4628 ;DOI: 10.1161/STROKEAHA.118.024578 ;PMID: 31084334

Full text available

18
Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time
Material Type:
Article
Add to My Research

Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time

Archives of ophthalmology (1960), 2022-10, Vol.140 (10), p.936 [Peer Reviewed Journal]

Copyright American Medical Association Oct 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.3130

Full text available

19
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study
Material Type:
Article
Add to My Research

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

Diabetes care, 2010-11, Vol.33 (11), p.2399-2405 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2010 American Diabetes Association ;Copyright American Diabetes Association Nov 2010 ;2010 by the American Diabetes Association. ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc10-0493 ;PMID: 20980427 ;CODEN: DICAD2

Full text available

20
NSAIDs and Corticosteroids for the Postoperative Management of Age-Related Cataract Surgery: A Systematic Review and Meta-analysis
Material Type:
Article
Add to My Research

NSAIDs and Corticosteroids for the Postoperative Management of Age-Related Cataract Surgery: A Systematic Review and Meta-analysis

American journal of ophthalmology, 2024-04, Vol.260, p.1-13 [Peer Reviewed Journal]

2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.09.027 ;PMID: 37797866

Full text available

Results 1 - 20 of 6,056  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,606)

Refine My Results

Creation Date 

From To
  1. Before 1975  (405)
  2. 1975 To 1986  (451)
  3. 1987 To 1998  (710)
  4. 1999 To 2011  (1,827)
  5. After 2011  (2,672)
  6. More options open sub menu

Language 

  1. English  (5,832)
  2. Japanese  (855)
  3. German  (89)
  4. Portuguese  (80)
  5. French  (64)
  6. Spanish  (58)
  7. Chinese  (9)
  8. Czech  (6)
  9. Norwegian  (6)
  10. Turkish  (5)
  11. Russian  (3)
  12. Polish  (3)
  13. Italian  (2)
  14. Swedish  (2)
  15. Serbian  (1)
  16. Korean  (1)
  17. Icelandic  (1)
  18. Ukrainian  (1)
  19. Croatian  (1)
  20. More options open sub menu

Searching Remote Databases, Please Wait